Assays for cytokines

The Cytokine Handbook

Volumn , Issue , 2003, Pages 1375-1396

  Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846816088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50065-X     Document Type: Chapter

References (122)

1. Abe M., Harpel J.G., Metz D.N., et al. An assay for transforming growth-factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter luciferase construct. Anal. Biochem. 1994, 216:276-282.
2. Human Cytokines: Their Role in Disease and Therapy 1995, Blackwell Science, Cambridge, MA. B.B. Aggarwal, R.K. Puri (Eds.).
3. Anderson N.L., Matheson A.D., Steiner S. Proteomics: applications in basic and applied biology. Curr. Opin. Biotech. 2000, 11:408-412.
4. Asai T., Storkus W.J., Whiteside T.L. Evaluation of the modified ELISPOT assay for interferon-γ production in cancer patients receiving anti-tumor vaccines. Clin. Diagn. Lab. Immunol. 2000, 7:145-154.
5. Aziz N., Nishanian P., Mitsuyasu R., et al. Variables that affect assays for plasma cytokines and soluble activation markers. Clin. Diagn. Lab. Immunol. 1998, 6:89-95.
6. Aziz N., Nishanian P., Fahey J. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin. Diagn. Lab. Immunol. 1999, 5:755-761.
7. Bargetzi M.J., Lantz M., Smith C.G., et al. Interleukin 1-β induces interleukin 1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res. 1993, 53:4010-4013.
8. Bennouna J., Hildesheim A., Chikamatsu K., et al. Application of IL-5 ELSIPOT assays to quantification of antigen-specific T helper responses. J. Immunol. Meth. 2002, 261:145-156.
9. Bienvenu J.A., Monneret G., Gutowski M.C., Fabien N. Cytokine assays in human sera and tissues. Toxicol. 1998, 129:55-61.
10. Boyden S. The chemotacitic effect of mixtures of antibody and antigen of polymorphonuclear leukocytes. J. Exp. Med. 1962, 115:453.
11. Bromley L., McCarthy S., Stickland J.E., et al. Non-isotopic in situ detection of mRNA for interleukin 4 in archival human tissue. J. Immunol Meth. 1997, 167:47-54.
12. Buttke T.M., McCubrey J.A., Owen T.C. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Meth. 1993, 157:223.
13. Callard R.E., Sheilds J.G., Smith S.H. Assays for human B cell growth and differentiation factors. Lymphokines and Interferons. A Practical Approach 1987, 345-364. IRL Press, Oxford. M.J. Clemns, A.G. Morris, A.J.H. Gearing (Eds.).
14. Cannon J.G., van der Meer J.W.M., Kwiatkowski D., et al. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine. Res. 1988, 7:457-467.
15. Cannon J.G., Nerad J.L., Poutsiaka D.D., Dinarello C.A. Measuring circulating cytokines. J. Appl. Physiol. 1993, 75:1897-1902.
16. Carding S.R., Lu D., Bottomly K. A polymerase chain reaction assay for the detection and quantification of cytokine gene expression in small numbers of cells. J. Immunol. Meth. 1992, 151:277-287.
17. Carson R.T., Vignali D.A.A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Meth. 1999, 227:41-52.
18. Chupp G.L., Wright E.A., Wu D., et al. Tissue and T cell distribution of precursor and mature IL-16. J. Immunol. 1998, 161:3114-3119.
19. Czerkinsky C., Andersson G., Ekre H.P., et al. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of γ-interferon-secreting cells. J. Immunol Meth. 1988, 110:29-36.
20. Deaver D.R. A new non-isotopic detection system for immunoassays. Nature 1995, 377:758-760.
21. DeForge L.E., Remick D.G. Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol. Invest. 1991, 20:89-97.
22. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression and germinal center formation by Bcl-6. Science 1997, 276:589-592.
23. Dinarello C.A. Interleukin 1 and interleukin 1 antagonism. Blood 1991, 72:1627-1652.
24. Dinarello C.A. ELISA kits based on monoclonal antibodies do not measure total IL-2 synthesis. J. Immunol. Meth. 1992, 148:255-259.
25. Dinarello C.A., Wolff S.M. Mechanisms of disease: the role of interleukin 1 in disease. N. Engl. J. Med. 1993, 328:106-113.
26. Dinarello C.A., Kluger M.J., Powanda M.C. The Physiological and Pathological Effects of Cytokines 1990, Liss, New York.
27. Dinarello C.A., Novick D., Puren A.J., et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J. Leukocyte Biol. 1998, 63:658-664.
28. Doherty P.C. The numbers game for virus-specific CD8+ T cells. Science 1998, 280:227.
29. Doyle A.G., Herbein G., Montaner L.J., et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-14 and interferon gamma. Eur. J. Immunol. 1994, 24:1441-1445.
30. Engelberts I., Stephens S., Francot G.J., et al. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids (letter). Lancet 1991, 338:515-516.
31. Foster J.R. The functions of cytokines and their uses in toxicology. J. Exp. Pathol. 2001, 82:171-192.
32. Friberg D., Bryant J., Shannon W., Whiteside T.L. In vitro cytokine production by normal human peripheral blood mononuclear cells to measure their immunocompetence and state of activation. Clin. Diagn. Lab. Immunol. 1994, 1:261-268.
33. Gallay P., Mach J.P., Carrel S. Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma. Eur. Cytokine Network 1991, 2:329-338.
34. Gibson U.E., Kramer S.M. Enzyme-linked bioimmunoassay for IFN-γ by HLA-DR induction. J. Immunol. Meth. 1989, 125:105-131.
35. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res 1996, 6:995-1001.
36. Gilliand G., Perrin S., Blanchard K., Bunn H.F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl Acad. Sci. USA 1990, 87:2725-2729.
37. Gillis S., Ferm M.M., Ou W.E., Smith K.A. T cell growth gactor: parameters of production and a quantitative microassay for activity. J. Immunol. 1978, 120:2027.
38. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 2000, 181:176-180.
39. Gonzalez S., Beck L., Wilson N. Comparison of interferon-γ and interleukin-4 production by peripheral blood mononuclear cells and isolated T-cells after activation with polyclonal T-cell activators. J. Clin. Lab. Analysis 1994, 8:277-283.
40. Goodwin C.J., Holt S.J., Downes S., Marshall N.J. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Meth. 1995, 179:95-103.
41. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., et al. A role for TH1 and Th2 cells in the immunopatheogenesis of atopic dermatitis. Immunol. Today 1998, 19:539.
42. Heid C.A., Stevens J., Livak K.J., William P.M. Real time quantitative CPR. Genome Res. 1996, 6:986-994.
43. Herr W., Wolfel T., Heike K.-H., et al. Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunol. Immunother. 1994, 39:93-99.
44. Herr W., Schneider J., Ansgar L.W., et al. Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor-α in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Meth. 1996, 191:131-142.
45. Herr W., Linn B., Leister N., Wandel E. The use of computer-assisted video image analysis for the quantitation of CD8+ T lymphocytes producing tumor necrosis factor-α spots in response to peptide antigens. J. Immunol. Meth. 1997, 203:141-151.
46. Herzyk D.J., Berger A.E., Allen J.N., Wewers M.D. Sandwich ELISA formats designed to detect 17 kDa IL-1 beta significantly underestimate 35 kDa IL-1 beta. J. Immunol. Meth. 1992, 148:243-254.
47. Higuchi M., Singh S., Aggarwal B.B. Characterization of the apoptotic effects of human tumor necrosis factor: development of highly rapid and specific bioassay for human tumor necrosis factor and lymphotoxin using human target cells. J. Immunol. Meth. 1995, 178:173-181.
48. Hu-Li J., Ohara J., Watson C., et al. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. Meth. 1989, 142:800.
49. Ishiyama M., Tominaga H., Shiga M., et al. A combined assay of cell viability and in vitro cytotoxicity with c highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharmaceut. Bull. 1996, 19:1518-1520.
50. James K. Interactions between cytokines and α-2 macroglobulin. Immunol. Today 1990, 11:163-166.
51. Jung T., Schauer U., Heusser C., et al. Detection of intracellular cytokines by flow cytometry. J. Immunol. Meth. 1993, 159:197-207.
52. Junger W.G., Cardoza T.A., Liu F.C., et al. Improved rapid photometric assay for quantitative measurement of PMN migration. J. Immunol. Meth. 1993, 160:73.
53. Konishi K., Tanabe F., Taniguchi M., et al. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Meth. 1997, 209:187-191.
54. Kruse N., Pette M., Toyka K., Rieckman P. Quanitfication of cytokine mRNA expression by RT-PCR in samples of previously frozen blood. J. Immunol. Meth. 1997, 210:195-203.
55. Labalette-Houache M., Torpier G., Capron A., Dessaint J.P. Improved permeabilisation procedure for flow cytometric detection of internal antigens. Analysis of interleukin-2 production. J. Immunol. Meth. 1991, 138:143-153.
56. Lalvani A., Brookes R., Hambleton S., et al. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 1997, 186:859-864.
57. Larrick J.W. Native interleukin 1 inhibitors. Immunol. Today 1989, 10:61-66.
58. Lewis C.E., Campbell A. Visualising the production of cytokines and their receptors by single human cells. Cytokines: A Practical Approach 1995, 339-356. IRL Press, Oxford. F.R. Balkwill (Ed.).
59. Lewis J.A. Antiviral activity of cytokines. Cytokines. A Practical Approach 1995, 129-141. IRL Press, Oxford. F.R. Balkwill (Ed.).
60. Lewis J.A. A sensitive biological assay for interferons. J. Immunol. Meth. 1995, 185:9-17.
61. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infections, neoplastic and inflammatory diseases. Clin. Microbiol. Rev. 1996, 9:532-562.
62. Manz R., Assenmadrer M., Pfluger E., et al. Analysis and sorting of live cells according to to secreted molecules relocated to a cell-surface affinity matrix. Proc. Natl Acad. Sci. USA 1995, 92:1921-1925.
63. Marshall N.J., Goodwin C.J., Holt S.J. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Reg. 1995, 5:69-84.
64. May L.T., Viguet H., Kenney J.S., et al. High levels of 'complexed' interleukin 6 in human blood. J. Biol. Chem. 1992, 267:19698-19704.
65. Meidenbauer N., Harris D.T., Spitler L.E., Whiteside T.L. Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer. Prostate 2000, 43:88-100.
66. Meidenbauer N., Gooding W., Spitler L.E., et al. Recovery of ξ chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer. Br. J. Cancer 2002, 86:168-178.
67. Meager T. The Molecule Biology of Cytokines 1998, John Wiley & Sons, Chichester.
68. Mire-Sluis A.R., Thorpe R. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J. Immunol. Meth. 1998, 211:199-210.
69. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65:55-63.
70. Mosmann T.R., Li L., Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol. 1997, 9:87-92.
71. Munz C., Bickham K.L., Subklewe M., et al. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 2000, 191:1649-1660.
72. Naylor M.S., Relf M., Balkwill F.R. Northern analysis, ribonuclease protection, and in situ analysis of cytokine messenger RNA. Cytokines: A Practical Approach 1995, 35-56. IRL Press, Oxford. F.R. Balkwill (Ed.).
73. Nemzek J.A., Newcomb D.E., Call D.R., Remick D.G. Plasma interference in an enzyme-linked immunosorbent assay using a commercial matched antibody pair. Immunol. Invest. 1999, 28:209-221.
74. Nicholas J., Ruvolo V.R., Burns W.H., et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 1997, 3:287-292.
75. Oelke M., Moehrle U., Chen J., et al. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin. Cancer Res. 2000, 5:1997-2005.
76. O'Garra A., Vierra P. Polymerase chain reaction for detection of cytokine gene expression. Curr. Opin. Immunol. 1992, 4:211-215.
77. Okamoto Y., Abe T., Niwa T., et al. Development of a dual color enzyme-linked immunospot assay for simultaneous detection of murine T helper type 1-and T helper type 2-cells. Immunopharmacology 1998, 39:107-116.
78. Oppenheim J.J. Clinical Applications of Cytokines. Role in Pathogenesis, Diagnosis and Therapy 1993, Oxford University Press, New York.
79. Paciotti G.F., Baron D., Licinio J., et al. Novel enzyme immunoassays for the detection of the cytokines-interleukin 1-α and interleukin 2 in the circulation of normal subjects: 24-hour profiles. Prog. Neuroendocrin. Immunol. 1992, 5:21-30.
80. Pennica D., Nedwin G.E., Hayflick J.S., et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984, 312:724-729.
81. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-577.
82. Picker L.J., Singh M.K., Zdraveski Z., et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995, 86:1408-1419.
83. Pollack J.R., Perou C.M., Alizadeh A.A., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 1999, 23:41-46.
84. Prussin C. Cytokine flow cytometry: understanding cytokine biology at the single cell level. J. Clin. Immunol. 1997, 17:195-204.
85. Randall L.A., Wadhwa M., Thorpe R., Mire-Sluis A.R. A novel sensitive bioassay for transforming growth factor-β. J. Immunol. Meth. 1993, 164:61.
86. Remick D.G. Protein analysis and bioassays of cytokines and cytokine receptors. Manual of Clinical Laboratory Immunology 2002, 320-337. ASM Press, Washington, DC. R.R. Rose, R.G. Hamilton, B. Detrick (Eds.).
87. Remick D.G., Whiteside T.L. Measurements of cytokines. The Cytokine Reference 2000, Harcourt, San Diego, CA. J.J. Openheim, M. Feldman (Eds.).
88. Remick D.G., Scales W.E., Chensue S.W., Kunkel S.L. The pathophysiology of interleukins and tumor necrosis factors. Cellular Pathophysiology 1989, 41-89. CRC Press, Boca Raton. M. Sayeed (Ed.).
89. Reynolds C.W. Development and use of cytokine and growth factor potency standards. Manual of Clinical Laboratory Immunology 1997, 357-359. ASM Press, Washington, DC. N.R. Rose (Ed.).
90. Roehm W.M., Rodgers G.H., Hatfield S.M., Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Meth. 1991, 142:257.
91. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997, 18:263-266.
92. Romagnani S. The Th1/Th2 Paradigm in Disease 1997, R.G. Landes, Austin, TX.
93. Rossi M., Bonino P., Whiteside T., et al. Determination of cytokine production variability in normal individuals overtime. J. Am. Geriatic Soc. 1993, 41:SA3.
94. Rossio J.L. Cytokines and immune cell products. Manual of Clinical Laboratory Immunology 1997, 348-356. ASM Press, Washington, DC. N.R. Rose (Ed.).
95. Sadick M.D., Sliwkowski M.X., Nuijens A., et al. Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput kinase receptor activation enzyme-linked immunosorbant assay. Anal. Biochem. 1996, 235:207-214.
96. Sallusto R., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998, 187:875-883.
97. Sander B., Andersson J., Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 1991, 119:65-93.
98. Scheibenbogen C., Lee K.-H., Stevanovic S., et al. Analysis of the T-cell response to tumor and viral peptide antigens by an IFN-γ-ELISPOT assay. Int. J. Cancer 1997, 71:1-5.
99. Schroder J.M., Mroweitz U., Morita E., Christophers E. Purification and partial biochemical characterisation of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. Meth. 1987, 139:3474-3483.
100. Suminami Y., Elder E.M., Lotze M.T., Whiteside T.L. In situ IL4 gene expression in cancer patients treated with a genetically-modified tumor vaccine. J. Immunother. 1995, 17:238-248.
101. Tada H., Shiho O., Kuroshima K., et al. An improved colorimetric assay for interleukin 2. J. Immunol. Meth. 1986, 93:157-165.
102. Taub D.D., Lloyd A.R., Conlon K., et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 1993, 177:1809-1814.
103. Taub D.D., Key M.L., Clark D., Turcovski-Corrales S.M. Chemotaxis of T lymphocytes on extracellular matrix proteins. Analysis of the in vitro method to quantitate chemotaxis of human T cells. J. Immunol. Meth. 1995, 184:187-198.
104. Taub D.D., Proost P., Murphy W.J., et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 1995, 95:1370-1376.
105. Thavasu P.W., Longhurst S., Joel S.P., et al. Measuring cytokine levels in blood: importance of anticoagulants, processing and storage conditions. J. Immunol. Meth. 1992, 153:115-124.
106. Thorpe R., Wadhwa M., Gearing A.J.H., et al. Sensitive and specific immunoradio-metric assays for human interleukin-1γ. Lymphokine. Res. 1988, 7:119-127.
107. Thorpe R., Wadhwa M., Bird C., Mire-Sluis A.R. Detection and measurement of cytokines. Blood Rev. 1992, 6:133-148.
108. Vignali D.A.A. Multiplexed particle-based flow cytometric assay. J. Immunol. Meth. 2000, 243:243-255.
109. Vitolo D., Zerbe T., Kanbour A., et al. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int. J. Cancer 1992, 51:573-580.
110. Vitolo D., Vujanovic N.L., Rabinowich H., et al. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and Il-2-receptors in adherent NK cells. J. Immunol. 1993, 151:1926-1937.
111. Vitolo D., Kanbour A., Johnson J.T., et al. In situ hybridization for cytokine gene transcripts in the solid tumor microenvironment. Eur. J. Cancer 1993, 29A:371-377.
112. Vukmanovic-Stejic M., Vyas B., Gorak-Stolinska P., et al. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 2000, 95:231-240.
113. Wadhwa M., Thorpe R. Assays for cytokines. The Cytokine Handbook 1998, 357-392. Academic Press, New York. A.W. Thomson (Ed.).
114. Wadhwa M., Thorpe R., Bird C.R., Gearing A.J.H. Production of polyclonal and monoclonal antibodies to human granulocyte colony-stimulating factor (G-CSF) and development of immunoassays. J. Immunol. Meth. 1990, 128:211-217.
115. Wadhwa M., Bird C., Page L., et al. Quantitative biological assays for individual cytokines. Cytokines. A Practical Approach 1995, 357-392. IRL Press, Oxford. F.R. Balkwill (Ed.).
116. Wadhwa M., Dilger P., Meager T., et al. IL-4 and TNF-γ mediated proliferation of the human megakaryocytic line M-7ee is regulated by induced autocrine production of GM-CSF. Cytokine 1996, 8:900-909.
117. Waldrop S.L., Pitcher C.J., Peterson D.M., et al. Determination of antigen-specific memory/effector CD4+T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 1997, 99:1739-1750.
118. Whiteside T.L. Cytokine measurements and interpretation of cytokine assays in human disease. J. Clin. Immunol. 1994, 14:327-339.
119. Whiteside T.L. Cytokines and cytokine measurements in a clinical laboratory. Clin. Diagn. Lab. Immunol. 1994, 1:257-260.
120. Yu C.R., Peden K.W., Zaitseva M.B., et al. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J. Immunol. 2000, 164:1293-1305.
121. Zhang M., Gately M.K., Wang E., et al. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 1994, 93:1733-1739.
122. Zhao Y.X., Ljungdhal A., Olsson T., Tarkowski A. In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum. 1996, 39:959-967.